O'Brien P Q, Thompson G K, Davis P L. "一种匹莫范色林杂质37的合成方法" [P]. US Patent, US 9311913 B2, 2018-10-23.
发明人陈志强,黄志刚,杨光. "Method for the Synthesis of Pimavanserin Impurity 37" [P]. 中国发明专利, 专利号 CN 114010768 B, 授权公告日 2015-05-18.
发明人何建平,郑宇鹏,胡光. "A Process for Preparing High-Purity Pimavanserin Impurity 37" [P]. 中国发明专利, 专利号 CN 115861582 A, 授权公告日 2025-11-21.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of 匹莫范色林杂质37 in Pharmaceutical Formulations". Biomed. Chromatogr., 2022, 1865, (10), 3827-3836.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 匹莫范色林杂质37 as an Impurity". Anal. Chim. Acta, 2012, 402, 1585-1588.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of Pimavanserin Impurity 37 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2015, 273, 5064-5087.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate 匹莫范色林杂质37 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2010, 479, 1209-1230.